Wegovy 1 mg FlexTouch is a once-weekly injectable prescription medicine used for chronic weight management. It contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist, and is delivered via the user-friendly FlexTouch pre-filled pen.
Uses:
Wegovy is indicated for chronic weight management in:
- Adults with obesity (BMI ≥30), or
- Adults who are overweight (BMI ≥27) with at least one weight-related condition such as:
- Type 2 diabetes
- Hypertension (high blood pressure)
- Dyslipidemia (high cholesterol)
Used in combination with a reduced-calorie diet and increased physical activity.
Benefits:
- Proven to help reduce body weight over time
- Helps control appetite and cravings
- Improves markers of metabolic health (e.g., glucose levels, blood pressure)
- Once-weekly injection enhances treatment adherence
- Easy-to-use FlexTouch pen simplifies administration
Side Effects:
Common side effects:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Headache
- Dizziness
- Fatigue
- Indigestion or abdominal pain
Serious but rare side effects:
- Inflammation of the pancreas (pancreatitis)
- Gallbladder problems (e.g., gallstones)
- Kidney issues from dehydration
- Possible thyroid tumors (including medullary thyroid carcinoma)
Contraindications:
Do not use if you or a family member has a history of medullary thyroid carcinoma (MTC) or MEN 2 (Multiple Endocrine Neoplasia syndrome type 2).
Storage:
- Before first use: Store in the refrigerator at 2°C to 8°C (36°F to 46°F)
- Do not freeze. Discard if frozen.
- Protect from light and heat
- Keep out of reach of children